57.100
|
NHSN Registration Form
|
No change
|
Decrease the
number of respondents from 6,000 to 2,000.
|
The
NHSN Registration form is filled out only once by a facility
during the enrollment process. After completing this form, the
facility will never have to fill this out again. Furthermore, we
expect roughly 2,000 facilities to be enrolling in NHSN in 2013
due to various upcoming reporting mandates and expansion of NHSN
surveillance components.
This change results in
the decrease of 333 burden hours.
|
57.101
|
Facility Contact
Information
|
No change
|
Decrease the
number of respondents from 6,000 to 2,000.
|
The
Facility Contact Information form is filled out only once by a
facility during the enrollment process. After completing this
form, the facility will never have to fill this out again.
Furthermore, we expect roughly 2,000 facilities to be enrolling
in NHSN in 2013 due to various upcoming reporting mandates and
expansion of NHSN surveillance components.
This change results in
the decrease of 667 burden hours.
|
57.103
|
Patient Safety
Component-Annual Hospital Survey
|
Patient Safety
Component-Annual Facility Survey
|
Title
change to reflect change in instrument use.
Remove
“Managed care organization” from Ownership choices.
In
the Facility Characteristics section, remove subsection title
“For any Hospital except Long Term Care Hospitals”.
In
the Facility Characteristics section, change the sub-section
title “Number of beds set up and staffed” to “Number
of beds set up and staffed in the following location types (as
defined by CDC)”; remove the word “beds” from
the choices; remove the specialty care bed choice; and change
the wording to “All other inpatient locations”.
Allow
users to specify the version of antimicrobial susceptibility
standards used in their microbiology laboratory.
Reword the
question for C. difficile
testing methods within the facility’s microbiology
laboratory.
|
Title
change to reflect change in instrument use.
A
managed care organization is not a true type of ownership rather
it is more of an insurance product type and therefore should be
removed as a choice.
Long
Term Care Hospitals will have their own annual survey so this
phrase is no longer necessary on this form.
In
order to better validate the number of beds of each type
reported on the annual survey to the number of beds attributed
to each location mapped in the NHSN application, the text of
this subsection needs to be altered. Data on facility bed size
captured on the annual survey is used as part of risk adjustment
for SSI following certain operative procedures and may be used
in the future for risk adjusting other events.
This
change will allow users to more accurately specify the version
of antimicrobial susceptibility standards that are used in their
lab facilities without needing to update the question on the
form and in the application each year when the new version is
released.
The
clarification of question 13 within the microbiology lab
practices section will provide users with a more simplified
response and allow for more accurate risk adjustment of this
measure.
These changes do not
affect the estimated burden of this form.
|
57.104
|
Patient Safety
Component-Outpatient Dialysis Center Practices Survey
|
No change
|
Update
header instructions
Order
of questions and question numbers have changed
Change
wording of “check all that apply” to “select
all that apply” in questions: 3, 38a
Change
wording of “unit”/”dialysis unit” to
“facility”/”dialysis facility” in
questions: 6, 7, 9, and 10
Change
“CHRONIC hemodialysis patients” to “MAINTENANCE
hemodialysis patients” in questions: 12 and 19
Change
wording in questions: 5a, 7a, 8, 11, 13, 15, 19b, 20a, 25, 25a,
28, 32, 33, 35, 36, 37, 38, 41, and 42
Change/add
answer responses to questions: 5a, 10, 21, 21c, 21d, 26, 30
(change order), 31, 32, 33, 34, 38a, 39a, and 41
Change
spelling of “dietician” to “Dietitian”
Change
header text beginning Section F: spell-out “arteriovenous
(AV)”
In
association with question regarding antimicrobial locks, change
format of “prevent”
Following
question regarding the association with a group or chain of
dialysis centers, add required question: “If Yes, managed
or operated by”
Add
required question: “How many were hepatitis B surface
ANTIGEN (HBsAg) positive in the first week of January?”
Following
question regarding the testing of hepatitis C antibody, add
required question and appropriate answer responses: “If
Yes, How frequently? (select all that apply)”
Following
question regarding the testing of hepatitis C antibody, add
required question: “How many were hepatitis C virus
(anti-HCV) antibody positive in the first week of January?”
Following
question regarding refrigerating dialyzers, add required
question and appropriate answer responses: “How is
dialyzer header cleaning performed? (select all that apply)”
Following
question regarding refrigerating dialyzers, add required
question and appropriate answer responses: “Is there a
limit to the number of times a dialyzer is used?”
Add
required question and appropriate answer responses: “Do
technicians administer any IV medications (e.g., heparin,
saline)?”
Add
required question and appropriate answer responses: “Does
your facility participate in any national or regional infection
prevention initiatives?”
Add
required question and appropriate answer responses: “If
Yes, indicate the primary focus of the initiative(s): (if >1,
select all that apply)”
Add
required question and appropriate answer responses: “Do
you follow CDC-recommended Core interventions to prevent
bloodstream infections in hemodialysis patients?”
Add
required question and appropriate answer responses: “Indicate
the form of skin antiseptic used to prep fistula/graft sites”
Following
question regarding buttonhole cannulation among fistula
patients, add required question and appropriate answer
responses: “If Yes, Indicate for what patients”
Following
question regarding buttonhole cannulation among fistula
patients, add required question and appropriate answer
responses: “If Yes, Buttonhole cannulation is most often
performed by”
Add
required question and appropriate answer responses: “Indicate
the form of antiseptic/disinfectant used to prep the catheter
hubs”
Add
required question and appropriate answer responses: “Indicate
the form of antiseptic/disinfectant used at the exit site”
Add
required question and appropriate answer responses: “Of
your maintenance hemodialysis patients with a central line in
Question 32 (32d + 32e), how many received prophylactic
antimicrobial lock in the first week of January?”
Add
required question and appropriate answer responses: “Are
closed connector luer access devices used on hemodialysis
catheters?”
Following
question regarding closed connector luer access devices, add
required question and appropriate answer responses: “If
Yes, Indicate what kind”
Following
question regarding closed connector luer access devices, add
required question and appropriate answer responses: “If
Yes, Indicate for what patients”
Does
your facility use hemodialysis machine Waste Handling Option
(WHO) ports?
Are any patients
in your facility “bled onto the machine” (i.e.,
where blood is allowed to reach or almost reach the prime waste
receptacle or WHO port)?
|
Headers
instructions are being updated for consistency with supporting
materials.
Order
of questions and question numbers have been changed to make the
sequence of the survey flow more smoothly from one topic to
another.
“Check
all that apply” is being replaced by “select all
that apply” across NHSN dialysis documentation for
consistency.
“unit”
/ ”dialysis unit” is being replaced by “facility”
/ “dialysis facility” across NHSN dialysis
documentation for consistency.
“Chronic”
is being replaced by “maintenance” across NHSN
dialysis documentation for consistency.
Changes
in question wording are being made to provide clarity and
specification to the questions.
Changes/additions
to answer responses are being made to provide additional detail
to provided answers and/or to provide more clarity.
The
change in spelling of “Dietitian” is a reflection of
the change in acceptable spellings promoted by the professional
organization of dietitians.
“arteriovenous”
is included in the first line of text beginning Section F as
this is the first time “AV” is used as an
abbreviation.
The
format of “prevent” is being changed in association
with the question regarding antimicrobial locks to bring
attention to the word.
With
regards to being associated with a group or chain of dialysis
centers, the question “If Yes, managed or operated by”
was added to capture information pertaining to the management
and operations of the facility, which may be overseen by a group
or chain of dialysis centers different from the group or chain
of dialysis centers that owns the facility.
The
question “How many were hepatitis B surface ANTIGEN
(HBsAg) positive in the first week of January?” has been
added to capture more information regarding the prevalence of
hepatitis B surface ANTIGEN among the dialysis patients included
as denominators for NHSN dialysis event surveillance.
The
question regarding the frequency of testing for hepatitis C
antibody has been added to gather more information regarding
hepatitis C testing practices in dialysis facilities.
The
question “How many were antibody to hepatitis C virus
(anti-HCV) positive in the first week of January?” has
been added to capture more information regarding the prevalence
of antibody to hepatitis C virus among the dialysis patients
included as denominators for NHSN dialysis event surveillance.
The
question “How is dialyzer header cleaning performed?
(select all that apply)” has been added to capture more
information regarding the practices of cleaning and reprocessing
dialyzers performed by facilities.
The
question “Is there a limit to the number of times a
dialyzer is used?” has been added to capture more
information regarding the reprocessing procedures practiced by
the facilities.
The
question “Do technicians administer any IV medications
(e.g., heparin, saline)?” has been added to capture more
information about how patient care is delivered and who is
responsible for delivering the patient care.
The
question “Does your facility participate in any national
or regional infection prevention initiatives?” has been
added to gather data regarding the level of interest that
dialysis facilities have in participating in infection
prevention activities and initiatives.
The
question “If Yes, indicate the primary focus of the
initiative(s): (if >1, select all that apply)” has been
added to determine the key components of infection prevention
may be of greatest interest to dialysis facilities.
The
question “Do you follow CDC-recommended Core interventions
to prevent bloodstream infections in hemodialysis patients?”
has been added to determine the level of interest and degree to
which the CDC-recommended Core interventions to prevent
bloodstream infections in hemodialysis patients are
implemented.
The
question “Indicate the form of skin antiseptic used to
prep fistula/graft sites” has been added to determine what
types of skin antiseptics are most commonly used to prep
fistula/graft sites and to see how the usage compares with
recommendations.
With
regards to buttonhole cannulation among fistula patients, the
question “If Yes, Indicate for what patients” has
been added to gain a better understanding of the practice of
buttonhole cannulation and to determine if buttonhole
cannulation is being performed on home hemodialysis patients,
in-center patients, or both home and in-center hemodialysis
patients.
With
regards to buttonhole cannulation among fistula patients, the
question “If Yes, Buttonhole cannulation is most often
performed by” has been added to gain a better
understanding of the practice of buttonhole cannulation and to
determine if the action of cannulating via buttonhole is being
performed by a nurse, the patient, a technician, or someone
else.
The
question “Indicate the form of antiseptic/disinfectant
used to prep the catheter hubs” has been added to
determine what type of antiseptic/disinfectant are most commonly
used to prep the catheter hubs and to see how the usage compares
with recommendations.
The
question “Indicate the form of antiseptic/disinfectant
used at the exit site” has been added to determine what
type of antiseptic/disinfectant are most commonly used to prep
the catheter hubs and to see how the usage compares with
recommendations.
The
question “Of your maintenance hemodialysis patients with a
central line in Question 30 (30d + 30e), how many received
prophylactic antimicrobial lock in the first week of January?”
has been added to determine the frequency of which the
prophylactic antimicrobial locks are used.
The
question “Are closed connector luer access devices used on
hemodialysis catheters?” has been added to determine the
frequency of which the closed connector luer access devices
used.
With
regards to the use of closed connector luer access devices, the
question “If Yes, Indicate what kind” has been added
to determine what types of these access devices are actually
being used.
With
regards to the use of closed connector luer access devices, the
“If Yes, Indicate for what patients” has been added
to determine in what types of patients these access devises are
used.
The
question “Does your facility use hemodialysis machine
Waste Handling Option (WHO) ports?” has been added to
determine the prevalence of this practice and possible
correlation with infection rates.
The
question “Are any patients in your facility “bled
onto the machine” (i.e., where blood is allowed to reach
or almost reach the prime waste receptacle or WHO port)?”
has been added to determine the prevalence of this practice and
possible correlation with infection rates.
Additionally,
due to CMS mandated reporting, the number of respondents
increased from 5,500 to 5,700. Due to these changes, the burden
hours of this form increase by 3,050 hours.
|
57.105
|
Group Contact Information
|
No change
|
No changes
|
N/A
|
57.106
|
Patient Safety Monthly
Reporting Plan
|
No change
|
Under
the Device-Associated Module section, rename “VAP”
to “PedVAP” event and add new event type of “VAE”.
Under the
Procedure-Associated Module section, remove “PPP”
event.
|
Ventilator-associated
pneumonia (VAP) is one of many complications that can occur in
patients who are intubated and whose respirations are assisted
by mechanical ventilation. The current pneumonia criteria have
proven difficult to apply consistently across data collectors
and are not amenable to electronic data capture. Therefore, a
working group was convened to develop a new paradigm for
defining and tracking ventilator-associated complications,
including pneumonia. The details are provided elsewhere in this
submission (see VAE section). The current VAP event will be
restricted to pediatric patients only beginning in 2013 (hence
the renaming to PedVAP) and the new VAE will replace the former
VAP event for adult patients.
Post-procedure
pneumonia (PPP) events have seldom been reported to NHSN under
the Procedure-Associated Module and therefore, a decision has
been made to remove them from the surveillance protocol and
hence from this form.
These changes do not
affect the estimated burden however we have increased the average
number of responses per year to 12 based on user feedback.
Increasing the number of responses per year increases the burden
of this form by 38,500 hours.
|
57.108
|
Primary Bloodstream
Infection (BSI)
|
No change
|
Revision of
‘Underlying Conditions’ section that now only
includes three check boxes.
|
The
revision of these items and collection of data on the presence
of these underlying conditions will be used to classify
laboratory confirmed bloodstream infections due to mucosal
barrier injuries (MBI-LCBI). This new LCBI classification will
increase the specificity of the central line associated
bloodstream infection (CLABSI) definition that is used for
surveillance, quality measurement and public reporting. This
modification to the definition is only for use in defined
patient populations. Therefore, the additional burden (estimated
to be 2 minutes) to collect these items will not impact all NHSN
facilities and locations, only those facilities and locations
providing care to specific patient populations.
These
changes result in 7200 added burden hours.
|
57.109
|
Dialysis Event
|
No change
|
Number
of times respondent completes form annually decreases from 75 to
60.
Add
an optional new question “Was the patient
admitted/readmitted to the dialysis facility on the same day as
this dialysis event?”
Modify
“Other access device (e.g., hybrid)” to “Other
access device” and add an optional sub-question “Is
this a catheter-graft hybrid?”
Add
an optional “Vascular access comment” text box.
Under “Positive
blood culture” modify instructions from “specify
pathogen” to “specify organism”.
|
Following
the discontinuation of “hospitalization” as a
stand-alone dialysis event and addition of the new “pus,
redness, or increased swelling at the vascular access site”
event in June 2011, facilities had fewer triggers to complete a
Dialysis Event form, which is reflected by reduced estimate of
60 dialysis event forms completed per facility annually.
Some
dialysis events are reported by dialysis centers, but are
attributable to the care they have received in other healthcare
settings (e.g., hospitals). This question will provide
additional information to distinguish these events from the ones
that occur as a result of care provided by the dialysis facility
doing the reporting.
Hybrid
access devices are relatively new and this sub-question will
allow us to determine what proportion they are of “other
access devices”. This will inform whether a stand-alone
hybrid category is needed for further risk stratification.
A
vascular access comment box will permit users to add additional
information about the patient’s accesses, to assist them
in interpreting their own data (e.g., if a patient has more than
1 of the same type, specify graft material, etc.)
For
dialysis reporting, all positive blood cultures are reported,
including non-pathogens. This modification will clarify the form
to be more consistent with reporting instructions.
Additionally, due to
CMS mandated reporting, the number of respondents increased from
5,500 to 5,700. However, these changes decrease the estimated
burden of this form by 18,800 hours.
|
57.111
|
Pneumonia (PNEU)
|
No change
|
The
post-procedure pneumonia field will be made optional instead of
required.
|
After
reviewing the data submitted to NHSN, use of the post-procedure
pneumonia surveillance is extremely limited. Furthermore,
in-plan pneumonia surveillance for adult patients will no longer
be available within NHSN as of January 2013.
This
change does not affect the estimated burden.
|
57.112
|
Ventilator-Associated
Event
|
Streamlined
Ventilator-Associated Pneumonia (SVAP)
|
The
entire event details section of the form was reworked to reflect
refinement of the surveillance definition algorithm.
Additional
question was added to Airway Pressure Release Ventilation (APRV)
status.
The form was
re-titled to more accurately reflect the events that will be
captured.
|
The
changes to the form are the result of work done by the VAP
Surveillance Definition Working Group, a group composed of CDC
staff, other federal partners, and leaders of external
stakeholder organizations in order to further define the
surveillance algorithm for detecting ventilator-associated
events.
APRV
is a mode of mechanical ventilation that is increasingly being
used in some centers, and may potentially be used in higher-risk
patients. Question was added to obtain a better understanding
for how commonly this mode is being used and how frequently
events are detected in patients receiving this kind of
mechanical ventilation.
The
form was re-titled to more accurately reflect the events that
will be captured.
These changes do not
affect the estimated burden.
|
57.114
|
Urinary Tract Infection
(UTI)
|
No change
|
Add
birthweight as an optional field.
Modify text of the
two choices of urinary catheter status at time of specimen
collection from 48 hours to 2 days.
|
To
allow matching of birthweight-specific urinary tract infection
events with the appropriate birthweight-specific denominator
data for rate calculations.
To
align with attribution timing rules that changed from 48 hours
to 2 days.
This change does not
affect the estimated burden.
|
57.116
|
Denominators for Neonatal
Intensive Care Unit (NICU)
|
No change
|
No changes
|
N/A
|
57.117
|
Denominators for Specialty
Care Area (SCA)/Oncology (ONC)
|
Denominators for Specialty
Care Area (SCA)
|
Title
change to reflect change in instrument use.
Sub-column of
number of patients on Airway Pressure Release Ventilation (APRV)
was added under ventilator category.
|
Title
change to reflect change in instrument use.
APRV
is a mode of mechanical ventilation that is increasingly being
used in some centers, and may potentially be used in higher-risk
patients. Question was added to obtain a better understanding
for how commonly this mode is being used and how frequently
events are detected in patients receiving this kind of
mechanical ventilation.
These
changes do not affect the estimated burden.
|
57.118
|
Denominators for Intensive
Care Unit (ICU)/Other Locations (Not NICU or SCA)
|
No change
|
Sub-column of
number of patients on Airway Pressure Release Ventilation (APRV)
was added under ventilator category.
|
APRV
is a mode of mechanical ventilation that is increasingly being
used in some centers, and may potentially be used in higher-risk
patients. Question was added to obtain a better understanding
for how commonly this mode is being used and how frequently
events are detected in patients receiving this kind of
mechanical ventilation.
This change does not
affect the estimated burden.
|
57.119
|
Denominator for Outpatient
Dialysis
|
No change
|
Update
header instructions.
Change
the wording of “Number of Chronic Hemodialysis Patients”
to “Number of Maintenance Hemodialysis Patients”.
Modify wording of
“optional fields” to “custom fields”
|
Headers
instructions are being updated for consistency with supporting
materials.
“Chronic”
is being replaced by “maintenance” across NHSN
dialysis forms for consistency.
Changing
wording to “custom fields” is to match the
terminology already in use in the application.
Additionally, due to
CMS mandated reporting, the number of respondents increased from
5,500 to 5,700. These changes add 240 burden hours to the ICR.
|
57.120
|
Surgical Site Infection
(SSI)
|
No change
|
No changes
|
N/A
|
57.121
|
Denominator for Procedure
|
No change
|
Remove
“Implant” field.
Rename “Endoscope”
field to “Scope”.
|
Capturing
data on implants has been very difficult and time consuming for
data collectors and is subject to considerable variability in
interpretation and documentation in the operative note. As a
result, the data have not been as useful for risk adjustment as
anticipated. Therefore, we plan to eliminate the collection of
this variable.
The
term “endoscope” has a broader definition than is
intended for this data collection. Therefore, we will change the
term to “scope” and more clearly define the subset
of scopes to be included.
This change decreases
burden by 3 minutes per response for an overall decrease of
162,000 burden hours.
|
57.123
|
Antimicrobial Use and
Resistance (AUR)-Microbiology Data Electronic Upload
Specification Tables
|
No change
|
Edits made to
requested variables and form reformatted.
|
Edits
were made to the requested variables to accurately reflect
changes in the requested data.
This
change does not affect the estimated burden.
|
57.124
|
Antimicrobial Use and
Resistance (AUR)-Pharmacy Data Electronic Upload Specification
Tables
|
No change
|
Edits made to
requested variables and form reformatted.
|
Edits
were made to the requested variables to accurately reflect
changes in the requested data.
This
change does not affect the estimated burden.
|
57.125
|
Central Line Insertion
Practices Adherence Monitoring
|
No change
|
No changes
|
N/A
|
57.126
|
MDRO or CDI Infection Form
|
No change
|
No changes
|
N/A
|
57.127
|
MDRO and CDI Prevention
Process and Outcome Measures Monthly Monitoring
|
No change
|
No changes
|
N/A
|
57.128
|
Laboratory-identified MDRO
or CDI Event
|
No change
|
No changes
|
N/A
|
57.130
|
Vaccination Monthly
Monitoring Form-Summary Method
|
No change
|
No changes
|
N/A
|
57.131
|
Vaccination Monthly
Monitoring Form-Patient-Level Method
|
No change
|
No changes
|
N/A
|
57.133
|
Patient Vaccination
|
No change
|
No changes
|
N/A
|
57.137
|
Long-Term Care Facility
Component – Annual Facility Survey
|
Patient Safety
Component-Annual Facility Survey for LTCF
|
Title
change to reflect change in instrument use.
Change
in format for collecting data of number of resident by primary
service type from annual prevalence to a point prevalence for a
single day.
Question
regarding C. difficile testing method used has been added.
Several questions
with minor editing to enhance clarity of questions asked.
|
Title
change to reflect change in instrument use.
New
form for data is easier to collect (now a day point prevalence
instead of annual percentage) and enables the ability to
distinguish between 0 (service not provide) and 0 (service
provided, but no residents in that service type on this day).
For
consistency with all other NHSN Annual Facility Surveys C.
difficile testing
methods has been added. This information is important as it has
shown to be significantly associated with C.
difficile rates,
and thus can be used for facility risk adjustment.
Per
user feedback, several questions were edited to enhance clarity.
While these changes do
not affect the estimated burden, the time burden was increased
from 25 minutes to 45 minutes per feedback from pilot users. This
increases the total burden for this form by 83 hours.
|
57.138
|
Laboratory-identified MDRO
or CDI Event for LTCF
|
No change
|
No changes
|
N/A
|
57.139
|
MDRO and CDI Prevention
Process Measures Monthly Monitoring for LTCF
|
No change
|
Increase the
number of times the form is filled out from 3 to 12.
|
The
number of times a respondent would fill out this form is
increasing due to pilot user feedback.
These changes result in
an increase of 188 burden hours.
|
57.140
|
Urinary Tract Infection
(UTI) for LTCF
|
No change
|
Addition
of question about presence if indwelling urinary catheter on
presentation to facility.
Text
edits to questions about presence of, date of insertion,
location of insertion of indwelling urinary catheter, and change
to format of question about presence of other urinary devices
present.
Text
edits to Laboratory and Diagnostics check boxes.
Died
within 30 days changes to within 7 days.
“Transferred
to acute care” changed to “Transferred to acute care
within 7 days”.
Removed “Date
of transfer” question.
|
Information
from pilot of surveillance forms indicated the need for several
clarifications of language in the Catheter Status section of
this form.
Information
from pilot of surveillance forms indicated the need for several
clarifications of language in the Catheter Status section of
this form.
Information
from pilot of surveillance forms indicated the need for
clarification to language in the Laboratory and Diagnostics
section of this form.
Changes
to increase reliability, reduce length of follow-up period, and
reduce data collection burden.
Changes
to increase reliability, reduce length of follow-up period, and
reduce data collection burden.
No
longer necessary as preceding question changed to include a
seven day follow-up interval.
These changes result in
no change of the estimated burden.
|
57.141
|
Monthly Reporting Plan for
LTCF
|
No change
|
No changes
|
N/A
|
57.142
|
Denominators for LTCF
Locations
|
No change
|
Addition of
column for ‘Resident Admissions”.
|
This
data was previously required for surveillance and is obtained
from facility administrative databases; however, the prior
version of this form had no place to record this information.
This change does not
affect the estimated burden.
|
57.143
|
Prevention Process
Measures Monthly Monitoring for LTCF
|
No change
|
No changes
|
N/A
|
57.150
|
Patient Safety Component-
Annual Facility Survey for LTAC
|
No change
|
Removal
of ‘Managed care organization’ from the facility
affiliation section.
Remove
the word ‘licensed’ from the description of LTAC
intensive care units.
Allow
users to specify the version of antimicrobial susceptibility
standards used in their microbiology laboratory.
Reword the
question for C. difficile
testing methods within the facility’s microbiology
laboratory.
|
After
review of the data, ‘Managed care organization’ was
not a meaningful affiliation type and therefore will be removed
from the form.
Further
clarification from users demonstrated that not all states
license LTAC intensive care unit beds. Therefore, in order to
get appropriate counts of LTAC beds, the qualifier of ‘licensed’
needs to be removed.
This
change will allow users to more accurately specify the version
of antimicrobial susceptibility standards that are used in their
lab facilities without needing to update the question on the
form and in the application each year when the new version is
released.
The
clarification of question 13 within the microbiology lab
practices section will provide users with a more simplified
response and allow for more accurate risk adjustment of this
measure.
These
changes do not affect the estimated burden of this form.
|
57.151
|
Patient Safety
Component-Annual Facility Survey for IRF
|
No change
|
Removal
of ‘Managed care organization’ from the facility
affiliation section.
Allow
users to specify the version of antimicrobial susceptibility
standards used in their microbiology laboratory.
Reword the
question for C. difficile
testing methods within the facility’s microbiology
laboratory.
|
After
review of the data, ‘Managed care organization’ was
not a meaningful affiliation type and therefore will be removed
from the form.
This
change will allow users to more accurately specify the version
of antimicrobial susceptibility standards that are used in their
lab facilities without needing to update the question on the
form and in the application each year when the new version is
released.
The
clarification of question 13 within the microbiology lab
practices section will provide users with a more simplified
response and allow for more accurate risk adjustment of this
measure.
These
changes do not affect the estimated burden of this form.
|
57.200
|
Healthcare Personnel
Safety Component Annual Facility Survey
|
No change
|
Decrease number
of respondents from 6,000 to 100.
|
In
the previous OMB submission, Form 57.200 was anticipated to
increase in participation with the addition of another module
under a CMS mandate within this Component; while the new module
will be added, this form will not be a required dependency for
users of the new module. The user base required to complete
form 57.200 will be considerably lower than previous estimates.
This change decreases
the estimated burden of this form by 47,200 hours.
|
57.202
|
Healthcare Worker Survey
|
No change
|
This form will
be removed from the package as it is retired from use.
|
Due
to reevaluation of the Healthcare Personnel Safety Component, it
was determined that Form 57.202 be retired from use as it was
never built into the NHSN application.
Removing
this form decreases the package burden by 10,000 hours.
|
57.203
|
Healthcare Personnel
Safety Monthly Reporting Plan
|
No change
|
Remove
‘Influenza Vaccination with Exposure Management/Treatment’
component from the Healthcare Personnel Vaccination Module
section of the form
Remove ‘quarterly’
from the description of the influenza vaccination summary
component
|
The
Healthcare Personnel Safety Component is being revised based on
the CMS mandate affecting acute care facilities. Therefore,
influenza exposure management/treatment will be moved into the
Healthcare Personnel Exposure Modules and removed from the
vaccination module.
Due
to the CMS mandated reporting of influenza vaccination status of
healthcare personnel within acute care facilities, this module
was revised to be a yearly summary instead of quarterly.
These changes do not
affect the estimated burden of this form.
|
57.204
|
Healthcare Worker
Demographic Data
|
No change
|
Decrease number
of respondents from 600 to 100.
|
Based
on analysis of current user base using Form 57.204, it is
unlikely that the number of respondents will exceed 100.
This change decreases
the estimated burden of this form by 33,333 hours.
|
57.205
|
Exposure to Blood/Body
Fluids
|
No change
|
Decrease number
of respondents from 600 to 100.
|
Based
on analysis of current user base using Form 57.205, it is
unlikely that the number of respondents will exceed 100.
This change decreases
the estimated burden of this form by 25,000 hours.
|
57.206
|
Healthcare Worker
Prophylaxis/Treatment
|
No change
|
Decrease
number of respondents from 600 to 100.
Increase the
number of annual responses from 10 to 30.
|
Based
on the user base, it is estimated that the number of
respondents, reduced to 100, is a more accurate reflection of
healthcare facilities that use this form.
This
form may be filled out more frequently for recording prophylaxis
and treatment outcomes than previously estimated.
These changes decrease
the burden of this form by 750 hours.
|
57.207
|
Follow-Up Laboratory
Testing
|
No change
|
Decrease
number of respondents from 600 to 100.
Decrease the
number of annual responses from 100 to 50.
|
Form
57.207 is required only if NHSN respondents opt for more
detailed surveillance post-exposure to a sharp or bite injury,
and based on current use of the module, at a maximum it is
anticipated that approximately 100 respondents.
Those
100 respondents would complete this form on 50 events per year
on average.
These changes decrease
the burden of this form by 13,750 hours.
|
57.208
|
Healthcare Worker
Vaccination History
|
No change
|
This form will
be removed from the package as it is retired from use.
|
Due
to reevaluation of the Healthcare Personnel Safety Component, it
was determined that Form 57.208 be retired from use as it was
never built into the NHSN application.
Removing
this form decreases the package burden by 30,000 hours.
|
57.209
|
Healthcare Worker
Influenza Vaccination
|
No change
|
This form will
be removed from the package as it is retired from use.
|
Due
to reevaluation of the Healthcare Personnel Safety Component, it
was determined that Form 57.209 be retired from use.
Removing
this form decreases the package burden by 50,000 hours.
|
57.210
|
Healthcare Worker
Prophylaxis/Treatment-Influenza
|
No change
|
No changes
|
N/A
|
57.211
|
Pre-season Survey on
Influenza Vaccination Programs for Healthcare Personnel
|
No change
|
This form will
be removed from the package as it is retired from use.
|
Due
to reevaluation of the Healthcare Personnel Safety Component, it
was determined that Form 57.211 be retired from use.
Removing
this form decreases the package burden by 100 hours.
|
57.212
|
Post-season Survey on
Influenza Vaccination Programs for Healthcare Personnel
|
No change
|
This form will
be removed from the package as it is retired from use.
|
Due
to reevaluation of the Healthcare Personnel Safety Component, it
was determined that Form 57.212 be retired from use.
Removing
this form decreases the package burden by 100 hours.
|
57.213
|
Healthcare Personnel
Influenza Vaccination Monthly Summary
|
No change
|
This form will
be removed from the package as it is retired from use.
|
Due
to reevaluation of the Healthcare Personnel Safety Component, it
was determined that Form 57.213 be retired from use.
Removing
this form decreases the package burden by 72,000 hours.
|
57.300
|
Hemovigilance Module
Annual Survey
|
No change
|
No changes
|
N/A
|
57.301
|
Hemovigilance Module
Monthly Reporting Plan
|
No change
|
No changes
|
N/A
|
57.302
|
Hemovigilance Module
Monthly Incident Summary
|
No change
|
No changes
|
N/A
|
57.303
|
Hemovigilance Module
Monthly Reporting Denominators
|
No change
|
No changes
|
N/A
|
57.304
|
Hemovigilance Adverse
Reaction
|
No change
|
Remove ‘Unit
collection date/time’ data fields within the Component
Details table
|
Per
user feedback, this information was too burdensome and not
feasible to collect at the unit level.
This
change does not affect the estimated burden.
|
57.305
|
Hemovigilance Incident
|
No change
|
No changes
|
N/A
|